Thalidomide drug molecule

Thalidomide drug molecule

A624/0159 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 34.3MB

Downloadable file size: 374.7KB

Price image Pricing

Please login to use the price calculator


Caption: Thalidomide (C13.H10.N2.O4) molecular model. The atoms are colour-coded: carbon (yellow), hydrogen (white), nitrogen (blue) and oxygen (red). This is R-thalidomide, a mirror image (enantiomer) of S- thalidomide, both of which share the same structural formula. Thalidomide was developed as a sedative drug to aid sleep in pregnant woman. It was found to cause foetal abnormalities (stunted limbs, or phocomelia), and was withdrawn in 1961. Further research discovered that only the "S" form caused deformities. A purified drug containing only the "R" enantiomer is now being used to treat leprosy and as an anti-cancer drug. See A624/155 for an image of S-thalidomide.

Release details: Model release not required. Property release not required.

Keywords: antineoplastic, artwork, atomic, atoms, biochemical, biochemistry, birth defects, chemical, chemistry, complications, compound, compounds, drug, enantiomer, hansen's disease, hansens disease, hypnotic, illustration, leprosy, model, molecular, molecule, molecules, pharmaceutical, pharmaceutics, phocomelia, pregnancy, r, r-thalidomide, sedative, sleeping, structural, structure, teratogen, thalidomide

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.